Given the absence of prescient laboratory or imaging findings in patients who develop type 1 diabetes on anti-PD-1 therapy, patients should be counseled on the symptoms of hyperglycemia which includes polyuria, polydipsia, abdominal pain, nausea and emesis and seek medical attention immediately. This evidence concerns the gene PDCD1 and type 1 diabetes mellitus.